|
18
|
99
|
3sabA |
Crystal structure of wild-type hiv-1 protease in complex with af78 |
|
99
|
387
|
3s7mA |
Pyrazolyl and thienyl aminohydantoins as potent bace1 inhibitors |
|
18
|
99
|
3sa9A |
Crystal structure of wild-type hiv-1 protease in complex with af68 |
|
102
|
387
|
3s7lA |
Pyrazolyl and thienyl aminohydantoins as potent bace1 inhibitors |
|
18
|
99
|
3s53A |
Hiv-1 protease triple mutants v32i, i47v, v82i with antiviral drug darunavir in space group p212121 |
|
90
|
387
|
3rviA |
Structure of bace-1 (beta-secretase) in complex with 2-((2-amino-6-o-tolylquinolin-3-yl)methyl)-n-(cyclohexylmethyl)pentanamide |
|
18
|
99
|
3s43B |
Hiv-1 protease triple mutants v32i, i47v, v82i with antiviral drug amprenavir |
|
16
|
99
|
3s45A |
Wild-type hiv-2 protease with antiviral drug amprenavir |
|
88
|
387
|
3s2oA |
Fragment based discovery and optimisation of bace-1 inhibitors |
|
19
|
99
|
3s43A |
Hiv-1 protease triple mutants v32i, i47v, v82i with antiviral drug amprenavir |
|
17
|
99
|
3s56A |
Hiv-1 protease triple mutants v32i, i47v, v82i with antiviral drug saquinavir |
|
88
|
387
|
3ru1A |
Structure of bace-1 (beta-secretase) in complex with 3-(2-aminoquinolin-3-yl)-n-(cyclohexylmethyl)propanamide |
|
19
|
99
|
3s54A |
Hiv-1 protease triple mutants v32i, i47v, v82i with antiviral drug darunavir in space group p21212 |
|
94
|
387
|
3rsxA |
Structure of bace-1 (beta-secretase) in complex with 6-(thiophen-3-yl)quinolin-2-amine |
|
91
|
387
|
3rtmA |
Structure of bace-1 (beta-secretase) in complex with 3-(2-aminoquinolin-3-yl)-n-cyclohexyl-n-methylpropanamide |
|
88
|
387
|
3rsvA |
Structure of bace-1 (beta-secretase) in complex with (r)-3-(2-amino-6-o-tolylquinolin-3-yl)-n-((r)-2,2-dimethyltetrahydro-2h-pyran-4-yl)-2-methylpropanamide |
|
92
|
387
|
3rtnA |
Structure of bace-1 (beta-secretase) in complex with 3-(2-amino-6-o-tolylquinolin-3-yl)-n-cyclohexylpropanamide |
|
90
|
387
|
3rthA |
Structure of bace-1 (beta-secretase) in complex with 6-(2-(3,3-dimethylbut-1-ynyl)phenyl)quinolin-2-amine |
|
84
|
330
|
3lzyA |
Crystal structure of endothiapesin in complex with xenon |
|
78
|
329
|
2vs2A |
Neutron diffraction structure of endothiapepsin in complex with a gem- diol inhibitor. |
|
18
|
99
|
5upjA |
Hiv-2 protease/u99283 complex |
|
91
|
389
|
5tolA |
Crystal structure of beta-site app-cleaving enzyme 1 complexed with n-(3-((4as,7as)-2-amino-4,4a,5,6-tetrahydro-7ah-furo[2,3-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-bromo-2-pyridinecarboxamide |
|
82
|
339
|
5t4sA |
Novel approach of fragment-based lead discovery applied to renin inhibitors |
|
86
|
339
|
5sy2A |
Structure-based design of a new series of n-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors |
|
87
|
337
|
5sz9A |
Structure-based design of a new series of n-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors |
|
89
|
337
|
5sy3A |
Structure-based design of a new series of n-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors |
|
85
|
330
|
5p3yA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 187 |
|
84
|
330
|
5p7qA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 323 |
|
83
|
330
|
5p38A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 161 |
|
83
|
330
|
5p59A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 234 |
|
83
|
330
|
5p5jA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 244 |
|
85
|
330
|
5p6wA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 293 |
|
86
|
330
|
5p2fA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 133 |
|
83
|
330
|
5p67A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 268 |
|
83
|
330
|
5p6gA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 277 |
|
84
|
330
|
5p20A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 119 |
|
84
|
330
|
5p62A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 263 |
|
84
|
330
|
5p40A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 189 |
|
81
|
330
|
5p2rA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 144 |
|
84
|
330
|
5p7nA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 320 |
|
83
|
330
|
5p6zA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 296 |
|
84
|
330
|
5p2jA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 137 |
|
82
|
330
|
5p5oA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 249 |
|
83
|
330
|
5p37A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 160 |
|
84
|
330
|
5p83A |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 336 |
|
83
|
330
|
5p2dA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 131 |
|
85
|
330
|
5p4nA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 212 |
|
83
|
330
|
5p8hA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 350 |
|
83
|
330
|
5p5yA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 259 |
|
84
|
330
|
5p2gA |
Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragment 134 |
